| Year |
Title |
Altmetric |
| 2021
|
Maintaining Normal Blood Pressure Across the Life Course: The JHS..
Hypertension.
77:1490-1499.
2021
|
|
| 2021
|
Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes..
Hypertension.
77:1391-1398.
2021
|
|
| 2021
|
Connecting Generations of Scientists in the Council on Hypertension Through Harriet Dustan.
Hypertension.
77:296-307.
2021
|
|
| 2021
|
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.
Hypertension.
77:435-444.
2021
|
|
| 2021
|
Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate”.
Current Hypertension Reports.
23.
2021
|
|
| 2021
|
Worsening Kidney Function Is the Major Mechanism of Heart Failure in Hypertension: The ALLHAT Study.
JACC: Heart Failure.
9:100-111.
2021
|
|
| 2021
|
Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?
2021
|
|
| 2021
|
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial).
American Journal of Kidney Diseases.
2021
|
|
| 2021
|
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
2021
|
|
| 2020
|
Concordance between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice.
JAMA Internal Medicine.
180:1655-1663.
2020
|
|
| 2020
|
Nocturnal blood pressure dipping in treated hypertensives: insights from the SPRINT trial..
European Journal of Preventive Cardiology.
2020
|
|
| 2020
|
Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
JAMA Network Open.
3:e2025127.
2020
|
|
| 2020
|
Salt and cardiovascular disease: Insufficient evidence to recommend low sodium intake.
European Heart Journal.
41:3363-3373.
2020
|
|
| 2020
|
The International Society of Hypertension Guidelines 2020–a new drug treatment recommendation in the wrong direction?
2020
|
|
| 2020
|
Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines.
Current Hypertension Reports.
22.
2020
|
|
| 2020
|
The Story of the Silent Killer: A History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debates.
Current Hypertension Reports.
22.
2020
|
|
| 2020
|
Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction.
ESC Heart Failure.
7:1700-1710.
2020
|
|
| 2020
|
Reserpine substantially lowers blood pressure in patients with refractory hypertension: A proof-of-concept study.
American Journal of Hypertension.
33:741-747.
2020
|
|
| 2020
|
To the Editor.
JAMA Internal Medicine.
180:1132-1133.
2020
|
|
| 2020
|
Weight Reduction for Obesity-Induced Heart Failure with Preserved Ejection Fraction.
Current Hypertension Reports.
22.
2020
|
|
| 2020
|
Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial?
2020
|
|
| 2020
|
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial.
Clinical Nephrology.
94:26-35.
2020
|
|
| 2020
|
Obesity, Hypertension, and Bariatric Surgery.
Current Hypertension Reports.
22.
2020
|
|
| 2020
|
Chronic hypertension in pregnancy.
American Journal of Obstetrics and Gynecology.
222:532-541.
2020
|
|
| 2020
|
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project
2020
|
|
| 2020
|
RE Letter to the Editor: Prehypertension is associated with multiple poor maternal and fetal outcomes, by Giovanni Sisti.
American Journal of Obstetrics and Gynecology.
222:514.
2020
|
|
| 2020
|
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers
2020
|
|
| 2020
|
Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertension.
Journal of Clinical Hypertension.
22:167-173.
2020
|
|
| 2020
|
The AJMS Celebrates # 200!.
American Journal of the Medical Sciences.
359:61-62.
2020
|
|
| 2020
|
The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.
Geroscience.
42:141-158.
2020
|
|
| 2020
|
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension
2020
|
|
| 2020
|
Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
Hypertension.
510-515.
2020
|
|
| 2020
|
Case of Episodic and Positional Hypertension: Diagnosis and Treatment.
Hypertension.
614-621.
2020
|
|
| 2020
|
Forty-year shifting distribution of systolic blood pressure with population hypertension treatment and control.
Circulation.
1524-1531.
2020
|
|
| 2020
|
Global Blood Pressure Screening: A Wakeup Call.
Hypertension.
318-320.
2020
|
|
| 2020
|
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results from SPRINT.
Hypertension.
660-667.
2020
|
|
| 2020
|
Report of the National Heart, Lung, and blood institute working group on hypertension barriers to translation.
Hypertension.
902-917.
2020
|
|
| 2020
|
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?
2020
|
|
| 2019
|
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of Diuretics.
JACC: Heart Failure.
7:1032-1041.
2019
|
|
| 2019
|
State of the Art: the Not-So-Great Wall of America.
Current Hypertension Reports.
21.
2019
|
|
| 2019
|
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes
2019
|
|
| 2019
|
Sex Differences in Hypertension and Stroke Risk in the REGARDS Study: A Longitudinal Cohort Study.
Hypertension.
74:749-755.
2019
|
|
| 2019
|
The PARAGON-Heart failure trial–another disappointment for heart failure patients with hypertension and preserved ejection fraction
2019
|
|
| 2019
|
Masked uncontrolled hypertension is not attributable to medication nonadherence.
Hypertension.
74:652-659.
2019
|
|
| 2019
|
Association of intensive vs standard blood pressure control with cerebral white matter lesions
2019
|
|
| 2019
|
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.
Hypertension.
74:276-284.
2019
|
|
| 2019
|
The PARAGON Heart Failure trial–ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction
2019
|
|
| 2019
|
Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
Circulation.
139:2542-2553.
2019
|
|
| 2019
|
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
2019
|
|
| 2019
|
Epicardial Adipose Tissue and Cardiovascular Disease.
Current Hypertension Reports.
21.
2019
|
|
| 2019
|
Plasma xanthine oxidase activity is related to increased sodium and left ventricular hypertrophy in resistant hypertension.
Free Radical Biology and Medicine.
134:343-349.
2019
|
|
| 2019
|
Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT.
Journal of Clinical Hypertension.
21:451-459.
2019
|
|
| 2019
|
Urinary biomarkers of tubular damage are associated with mortality but not cardiovascular risk among systolic blood pressure intervention trial participants with chronic kidney disease.
American Journal of Nephrology.
49:346-355.
2019
|
|
| 2019
|
Treatment of Resistant and Refractory Hypertension.
Circulation Research.
124:1061-1070.
2019
|
|
| 2019
|
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
2019
|
|
| 2019
|
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial
2019
|
|
| 2019
|
New data on antihypertensive drugs and risk of cancer: should we worry?
2019
|
|
| 2019
|
Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury
2019
|
|
| 2019
|
Lower blood pressure thresholds raise the bar in pregnancy.
Circulation Research.
125:195-197.
2019
|
|
| 2019
|
Out-of-Clinic Sympathetic Activity Is Increased in Patients with Masked Uncontrolled Hypertension.
Hypertension.
73:132-141.
2019
|
|
| 2018
|
PTH, FGF23, and intensive blood pressure lowering in chronic kidney disease participants in SPRINT.
Clinical Journal of the American Society of Nephrology.
13:1816-1824.
2018
|
|
| 2018
|
Obesity and Pulmonary Hypertension.
Current Hypertension Reports.
20.
2018
|
|
| 2018
|
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension
2018
|
|
| 2018
|
Association of Clinical and Social Factors with Excess Hypertension Risk in Black Compared with White US Adults
2018
|
|
| 2018
|
Novel Medical Treatments for Hypertension and Related Comorbidities.
Current Hypertension Reports.
20.
2018
|
|
| 2018
|
Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes
2018
|
|
| 2018
|
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study
2018
|
|
| 2018
|
Take a blood pressure pill or benefit from renal denervation?.
European Heart Journal.
39:3010-3012.
2018
|
|
| 2018
|
Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk.
Current Hypertension Reports.
20.
2018
|
|
| 2018
|
Final Farewell to Alberto Zanchetti MD..
European Heart Journal.
39:2616-2617.
2018
|
|
| 2018
|
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure
2018
|
|
| 2018
|
Case of refractory hypertension controlled after aortic and mitral valve replacement and coronary artery bypass grafting.
Hypertension.
72:3-9.
2018
|
|
| 2018
|
In memoriam: Alberto Zanchetti.
2018
|
|
| 2018
|
O-linked β-N-acetylglucosamine modification of A20 enhances the inhibition of NF-κB (nuclear factor-κB) activation and elicits vascular protection after acute endoluminal arterial injury
2018
|
|
| 2018
|
Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial).
Hypertension.
71:848-857.
2018
|
|
| 2018
|
Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.
Journal of Clinical Hypertension.
20:694-702.
2018
|
|
| 2018
|
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?
2018
|
|
| 2018
|
Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studies.
Hypertension.
71:326-335.
2018
|
|
| 2018
|
VEGF nanoparticles repair the heart after myocardial infarction
2018
|
|
| 2018
|
Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions
2018
|
|
| 2018
|
Impact of intensive versus standard blood pressure management by tertiles of blood pressure in SPRINT (Systolic Blood Pressure Intervention Trial).
Hypertension.
71:1064-1074.
2018
|
|
| 2018
|
Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes.
Hypertension.
72:343-349.
2018
|
|
| 2018
|
Sprinting toward the optimal blood pressure target for hypertensive patients.
Circulation Research.
123:531-534.
2018
|
|
| 2017
|
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
2017
|
|
| 2017
|
Masked Hypertension.
Current Hypertension Reports.
19.
2017
|
|
| 2017
|
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials
2017
|
|
| 2017
|
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
American Journal of Kidney Diseases.
70:357-367.
2017
|
|
| 2017
|
Regression of Left Ventricular Mass After Bariatric Surgery.
Current Hypertension Reports.
19.
2017
|
|
| 2017
|
White-Coat Effect Is Uncommon in Patients with Refractory Hypertension.
Hypertension.
70:645-651.
2017
|
|
| 2017
|
Incident cardiovascular disease among adults with blood pressure <140/90 mm Hg.
Circulation.
136:798-812.
2017
|
|
| 2017
|
Hypertension in Women: Recent Advances and Lingering Questions.
Hypertension.
70:19-26.
2017
|
|
| 2017
|
The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke
2017
|
|
| 2017
|
11-beta dehydrogenase type 2 activity is not reduced in treatment resistant hypertension.
American Journal of Hypertension.
30:518-523.
2017
|
|
| 2017
|
Distinctive Risk Factors and Phenotype of Younger Patients with Resistant Hypertension: Age is Relevant.
Hypertension.
69:827-835.
2017
|
|
| 2017
|
Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.
Current Hypertension Reports.
19.
2017
|
|
| 2017
|
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
Circulation: Heart Failure.
10.
2017
|
|
| 2017
|
Hypertension and Its Complications in a Young Man with Autoimmune Disease.
Hypertension.
69:536-544.
2017
|
|
| 2017
|
The INTERSALT Study and the complex relationship between salt intake and blood pressure
2017
|
|
| 2017
|
The technical report on sodiumintake and cardiovascular disease in low- and middleincome countries by the joint working group of theWorld Heart Federation, the European Society of Hypertension and the European Public Health Association.
European Heart Journal.
38:712-719.
2017
|
|
| 2017
|
On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults with Isolated Systolic Hypertension.
Hypertension.
69:220-227.
2017
|
|
| 2017
|
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.
Current Hypertension Reports.
19.
2017
|
|
| 2017
|
The Global Burden of Disease Study 2015 and Blood Pressure
2017
|
|
| 2017
|
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT.
Clinical Nephrology.
87:11-20.
2017
|
|
| 2017
|
Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults secondary analysis of a randomized clinical trial.
JAMA Internal Medicine.
177:67-76.
2017
|
|
| 2016
|
Smad3-mSin3A-HDAC1 Complex is Required for TGF-β1-Induced Transcriptional Inhibition of PPARγ in Mouse Cardiac Fibroblasts.
Cellular Physiology and Biochemistry.
40:908-920.
2016
|
|
| 2016
|
Blood Pressure in 2016: increased impact factor and change of editors
2016
|
|
| 2016
|
Should Patients with Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target?: A Protagonist View from the SPRINT Trial (Systolic Blood Pressure Intervention Trial).
Circulation.
134:1308-1310.
2016
|
|
| 2016
|
BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?.
Current Cardiology Reports.
18.
2016
|
|
| 2016
|
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients with Resistant Hypertension.
Hypertension.
68:995-1003.
2016
|
|
| 2016
|
The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease
2016
|
|
| 2016
|
The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.
Contemporary Clinical Trials.
50:238-244.
2016
|
|
| 2016
|
The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Hypertension.
68:39-45.
2016
|
|
| 2016
|
Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years a randomized clinical trial
2016
|
|
| 2016
|
Refractory hypertension: A novel phenotype of antihypertensive treatment failure.
Hypertension.
67:1085-1092.
2016
|
|
| 2016
|
Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement.
American Journal of Medicine.
129:372-378.
2016
|
|
| 2016
|
CardioPulse. The SPRINT trial results.
European Heart Journal.
37:924-927.
2016
|
|
| 2016
|
The SPRINT trial results.
European Heart Journal.
37:925-927.
2016
|
|
| 2016
|
Visit-to-visit variability of BP and CKD outcomes: Results from the ALLHAT.
Clinical Journal of the American Society of Nephrology.
11:471-480.
2016
|
|
| 2016
|
Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.
Hypertension.
67:550-555.
2016
|
|
| 2016
|
Targeted delivery of human iPS-ECs overexpressing IL-8 receptors inhibits neointimal and inflammatory responses to vascular injury in the rat
2016
|
|
| 2016
|
SPS3 Evidence Supports Intensive Blood Pressure Control.
Circulation.
133:552-554.
2016
|
|
| 2016
|
SPRINT Trial Results: Latest News in Hypertension Management.
Hypertension.
67:263-265.
2016
|
|
| 2016
|
The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg
2016
|
|
| 2016
|
Impact of renal denervation on patients with obstructive sleep apnea and resistant hypertension – Insights from the SYMPLICITY HTN-3 trial.
Circulation Journal.
80:1404-1412.
2016
|
|
| 2016
|
Should Antihypertensive Treatment Recommendations Differ in Patients with and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).
American Journal of Cardiology.
117:105-115.
2016
|
|
| 2015
|
Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality a cohort study.
Annals of Internal Medicine.
163:329-338.
2015
|
|
| 2015
|
Estrogen and cardiovascular disease: Is timing everything?.
American Journal of the Medical Sciences.
350:27-35.
2015
|
|
| 2015
|
Apparent treatment-resistant hypertension among individuals with history of stroke or transient ischemic attack.
American Journal of Medicine.
128:707-714.e2.
2015
|
|
| 2015
|
Treatment of Hypertension in Patients with Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.
Hypertension.
65:1372-1407.
2015
|
|
| 2015
|
Treatment of hypertension in patients with coronary artery disease: A scientific statement from the american heart association, american college of cardiology, and american society of hypertension.
Circulation.
131:e435-e470.
2015
|
|
| 2015
|
Regional Heterogeneity in 3D Myocardial Shortening in Hypertensive Left Ventricular Hypertrophy: A Cardiovascular CMR Tagging Substudy to the Life Study..
Journal of Biomedical Science and Engineering.
8:213-225.
2015
|
|
| 2015
|
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
European Heart Journal.
36:219-227.
2015
|
|
| 2015
|
New Approaches in the Treatment of Hypertension.
Circulation Research.
116:1074-1095.
2015
|
|
| 2015
|
Refractory hypertension: Evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure.
Hypertension.
66:126-133.
2015
|
|
| 2014
|
Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in hispanic/latino patients with hypertension: The trinity study.
Ethnicity and Disease.
24:41-47.
2014
|
|
| 2014
|
Update on Clinical Guidelines for Treatment of Hypertension.
Current Cardiovascular Risk Reports.
8:1-8.
2014
|
|
| 2014
|
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The systolic blood pressure intervention trial (SPRINT).
Clinical Trials.
11:532-546.
2014
|
|
| 2014
|
Guidelines for managing high blood pressure - Reply
2014
|
|
| 2014
|
Determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.
Hypertension.
63:451-458.
2014
|
|
| 2014
|
2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
2014
|
|
| 2014
|
Hypertension Management by Practice Guidelines
2014
|
|
| 2014
|
2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (JNC 8)
2014
|
|
| 2014
|
Chlorthalidone versus hydrochlorothiazide in hypertension treatment: Do we have the evidence to decide?.
American Journal of Kidney Diseases.
63:387-389.
2014
|
|
| 2014
|
Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: Results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Journal of Clinical Hypertension.
16:323-330.
2014
|
|
| 2014
|
Estrogen effects on vascular inflammation are age dependent: Role of estrogen receptors
2014
|
|
| 2014
|
Incident ESRD and treatment-resistant hypertension: The reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
63:781-788.
2014
|
|
| 2014
|
Proceedings from Duke resistant hypertension think tank.
American Heart Journal.
167.
2014
|
|
| 2014
|
Renal denervation in treatment-resistant hypertension-Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
2014
|
|
| 2014
|
Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension?.
Hypertension.
63.
2014
|
|
| 2014
|
Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling
2014
|
|
| 2014
|
Trends in hypertension prevalence, awareness, treatment, and control among us adults 80 years and older, 1988-2010.
Journal of Clinical Hypertension.
16:270-276.
2014
|
|
| 2014
|
Updated guidelines for management of high blood pressure in Japan.
Hypertension Research.
37:484-487.
2014
|
|
| 2013
|
Author Response to Lipid-Lowering in African Americans in ALLHAT-Optimism Bias?.
Journal of Clinical Hypertension.
15:941-941.
2013
|
|
| 2013
|
Revisiting the pre-hypertension debate: Increasing evidence for treatment-or not
2013
|
|
| 2013
|
Risk of Hospitalized Gastrointestinal Bleeding in Persons Randomized to Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker in ALLHAT.
Journal of Clinical Hypertension.
15:825-832.
2013
|
|
| 2013
|
The Human Side of Failed Hypertension Treatment.
Journal of Clinical Hypertension.
15:762-764.
2013
|
|
| 2013
|
Blood pressure lowering effect of renal sympathetic denervation or placebo? - Building expectations for Symplicity-HTN 3
2013
|
|
| 2013
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:1583-1590.
2013
|
|
| 2013
|
2013 European society of hypertension/European society of cardiology hypertension guidelines
2013
|
|
| 2013
|
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT).
Journal of Clinical Hypertension.
15:542-554.
2013
|
|
| 2013
|
Olmesartan/amlodipine/hydrochlorothiazide in obese participants with hypertension: A TRINITY subanalysis.
Journal of Clinical Hypertension.
15:584-592.
2013
|
|
| 2013
|
Ovarian hormones and vascular disease.
Current Opinion in Cardiology.
28:411-416.
2013
|
|
| 2013
|
Primary cardiovascular prevention by Mediterranean diet - The PREDIMED trial
2013
|
|
| 2013
|
Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction
2013
|
|
| 2013
|
Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial: Results by sex.
Hypertension.
61:977-986.
2013
|
|
| 2013
|
Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m2.
American Journal of Cardiology.
111:1131-1138.
2013
|
|
| 2013
|
Reply to Visit-to-Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study.
Journal of Clinical Hypertension.
15:301.
2013
|
|
| 2013
|
Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency.
European Heart Journal.
34:676-683.
2013
|
|
| 2013
|
Association Between Antihypertensive Medication Adherence and Visit-to-Visit Variability of Blood Pressure.
Journal of Clinical Hypertension.
15:112-117.
2013
|
|
| 2013
|
Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus.
Journal of Clinical Hypertension.
15:92-100.
2013
|
|
| 2013
|
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.
Chest.
143:978-983.
2013
|
|
| 2012
|
Angiotensin receptor - Neprilysin inhibiton (ARNI) A novel therapeutic concept for management of hypertension and heart failure
2012
|
|
| 2012
|
Blood Pressure Measurement Device, Number and Timing of Visits, and Intra-Individual Visit-to-Visit Variability of Blood Pressure.
Journal of Clinical Hypertension.
14:744-750.
2012
|
|
| 2012
|
Direct renin inhibitors in hypertension Approaching the moment of truth
2012
|
|
| 2012
|
Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction
2012
|
|
| 2012
|
Catheter-based renal denervation for resistant hypertension: Rationale and design of the SYMPLICITY HTN-3 trial
2012
|
|
| 2012
|
J Curve in Hypertension.
Current Cardiovascular Risk Reports.
6:281-290.
2012
|
|
| 2012
|
Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study..
American Journal of Cardiovascular Drugs.
12:233-243.
2012
|
|
| 2012
|
Triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: The trinity randomized, double-blind, 12-week, parallel-group study.
American Journal of Cardiovascular Drugs.
12:233-243.
2012
|
|
| 2012
|
Long-Term renal and cardiovascular outcomes in antihypertensive and Lipid-Lowering treatment to prevent heart attack trial (ALLHAT) participants by baseline estimated GFR.
Clinical Journal of the American Society of Nephrology.
7:989-1002.
2012
|
|
| 2012
|
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Hypertension.
59:926-933.
2012
|
|
| 2012
|
Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure
2012
|
|
| 2012
|
Endothelial cells overexpressing interleukin-8 receptors reduce inflammatory and neointimal responses to arterial injury.
Circulation.
125:1533-1541.
2012
|
|
| 2012
|
Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension.
Journal of Clinical Hypertension.
14:149-157.
2012
|
|
| 2012
|
Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension the ALLHAT diabetes extension study.
Circulation: Cardiovascular Quality and Outcomes.
5:153-162.
2012
|
|
| 2012
|
Antiplatelet therapy for transient ischemic attack.
Journal of Clinical Hypertension.
14:103-111.
2012
|
|
| 2012
|
Increased time varying heart rate and cardiovascular risk in hypertension Benefit of selective I (f) channel inhibitor?
2012
|
|
| 2012
|
Mortality and morbidity during and after the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Journal of Clinical Hypertension.
14:20-31.
2012
|
|
| 2012
|
Prevalence and Correlates of Low Medication Adherence in Apparent Treatment-Resistant Hypertension.
Journal of Clinical Hypertension.
14:694-700.
2012
|
|
| 2012
|
Refractory hypertension: Definition, prevalence, and patient characteristics.
Journal of Clinical Hypertension.
14:7-12.
2012
|
|
| 2012
|
Renal sympathetic denervation for treatment of hypertension.
Current Treatment Options in Cardiovascular Medicine.
14:127-135.
2012
|
|
| 2012
|
Within-Visit Variability of Blood Pressure and All-Cause and Cardiovascular Mortality Among US Adults.
Journal of Clinical Hypertension.
14:165-171.
2012
|
|
| 2011
|
24-Hour Efficacy and Safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: The TRINITY Ambulatory Blood Pressure Substudy.
Journal of Clinical Hypertension.
13:873-880.
2011
|
|
| 2011
|
An appropriate SCORE to assess cardiovascular risk in hypertension?
2011
|
|
| 2011
|
Can catheter-based renal denervation be used safely and effectively to substantially reduce blood pressure in treatment-resistant hypertensive patients?.
Current Cardiology Reports.
13:478-480.
2011
|
|
| 2011
|
Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling
2011
|
|
| 2011
|
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
Circulation.
124:1811-1818.
2011
|
|
| 2011
|
Renal nerve ablation: Emerging role in therapeutics
2011
|
|
| 2011
|
High mortality explained by mildly elevated blood pressure in Scandinavian adolescent conscripts A plea for early drug treatment?
2011
|
|
| 2011
|
Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
2011
|
|
| 2011
|
Response to intervisit blood pressure variability and outcome: Is heart rate a missing confounder?.
Hypertension.
58.
2011
|
|
| 2011
|
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the american college of cardiology foundation task force on clinical expert consensus documents.
Circulation.
123:2434-2506.
2011
|
|
| 2011
|
The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
Blood Pressure Monitoring.
16:87-95.
2011
|
|
| 2011
|
Treatment of high blood pressure in acute stroke - The SCAST Study
2011
|
|
| 2011
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A Guideline from the American Heart Association.
Circulation.
123:1243-1262.
2011
|
|
| 2011
|
The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994.
Hypertension.
57:160-166.
2011
|
|
| 2011
|
Antihypertensive therapy and cancer risks?
2011
|
|
| 2010
|
Cardiovascular risks in HIV patients
2010
|
|
| 2010
|
Comparison of the antihypertensive efficacy of irbesartan/HCTZ and valsartan/HCTZ combination therapy: Impact of age and gender.
Clinical and experimental hypertension.
32:499-503.
2010
|
|
| 2010
|
Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted?.
Current Cardiology Reports.
12:450-463.
2010
|
|
| 2010
|
Efficacy of an olmesartan medoxomil-based treatment algorithm in patients stratified by age, race, or sex.
Journal of Clinical Hypertension.
12:3-13.
2010
|
|
| 2010
|
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study
2010
|
|
| 2010
|
A stitch saves time and lowers blood pressure.
Current Hypertension Reports.
12:146-148.
2010
|
|
| 2010
|
C-reactive protein-mediated vascular injury requires complement
2010
|
|
| 2010
|
Prevention of Microalbuminuria in Patients With Type 2 Diabetes: What Do We Know?.
Journal of Clinical Hypertension.
12:422-430.
2010
|
|
| 2010
|
The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.
Hypertension.
55:1381-1388.
2010
|
|
| 2010
|
Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: A prospective clinical study.
Hypertension.
55:1137-1142.
2010
|
|
| 2010
|
Editorial: Blood pressure and migration
2010
|
|
| 2010
|
Editorial: Hypertension research into the new millennium
2010
|
|
| 2010
|
Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction.
Hypertension.
55:241-248.
2010
|
|
| 2010
|
Inhibition of transforming growth factor-β signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart
2010
|
|
| 2010
|
Angiotensin receptor blockers and cancer - Relationship dismissed by VALUE data while waiting for EMA and FDA reports
2010
|
|
| 2010
|
Editorial: Blood Pressure celebrates 20 years of dedication to Nordic hypertension research
2010
|
|
| 2010
|
Editorial: Blood pressure variability: Emerging role in risk assessment and therapeutics
2010
|
|
| 2010
|
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes.
Integrated Blood Pressure Control.
3:113-123.
2010
|
|
| 2009
|
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients?
2009
|
|
| 2009
|
The J-curve phenomenon revisited
2009
|
|
| 2009
|
Editorial: Critical aspects in hypertension diagnosis and treatment
2009
|
|
| 2009
|
Editorial: Should we treat prehypertension?
2009
|
|
| 2009
|
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: The Losartan Intervention for Endpoint reduction in hypertension study
2009
|
|
| 2009
|
Reduction of blood pressure in patients with treatment-resistant hypertension.
Expert Opinion on Pharmacotherapy.
10:2959-2971.
2009
|
|
| 2009
|
Safety and tolerability of fixed-dose irbesartanhydrochlorothiazide for rapid control of severe hypertension.
Clinical and experimental hypertension.
31:572-584.
2009
|
|
| 2009
|
Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: Evaluation by baseline hypertension stage and prior antihypertensive medication use.
Journal of Cardiovascular Pharmacology.
54:427-436.
2009
|
|
| 2009
|
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses: Reply.
Archives of Internal Medicine.
169:1810-1811.
2009
|
|
| 2009
|
Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial.
Hypertension.
54:475-481.
2009
|
|
| 2009
|
Hypertension in the Elderly.
Clinics in Geriatric Medicine.
25:391-412.
2009
|
|
| 2009
|
ONTARGET, TRANSCEND and PROFESS - Clarifying, confusing or misleading?
2009
|
|
| 2009
|
ASH Position Paper: Dietary approaches to lower blood pressure..
Journal of Clinical Hypertension.
11:358-368.
2009
|
|
| 2009
|
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Archives of Internal Medicine.
169:832-842.
2009
|
|
| 2009
|
Hormone therapy of premature ovarian failure the case for "natural" estrogen.
Hypertension.
53:745-746.
2009
|
|
| 2009
|
Loss of Thy-1 inhibits alveolar development in the newborn mouse lung
2009
|
|
| 2009
|
Estrogen and mechanisms of vascular protection
2009
|
|
| 2009
|
A true champion of Hungarian kidney research and nephrology education--tribute to László Rosivall..
Acta Physiologica Hungarica.
96:375-382.
2009
|
|
| 2009
|
Critical aspects in hypertension diagnosis and treatment
2009
|
|
| 2009
|
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
Journal of Clinical Hypertension.
11:475-482.
2009
|
|
| 2009
|
Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study.
American Heart Journal.
157:177-184.
2009
|
|
| 2009
|
Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system
2009
|
|
| 2008
|
Benefits of hypertension management in diabetes: An opportunity not to be missed
2008
|
|
| 2008
|
Combining RAAS and calcium channel blockade: ACCOMPLISH in perspective
2008
|
|
| 2008
|
More focus on therapeutic targets and improved tolerability in hypertension
2008
|
|
| 2008
|
Aliskiren and valsartan in stage 2 hypertension: Subgroup analysis of a randomized, double-blind study.
Advances in Therapy.
25:1288-1302.
2008
|
|
| 2008
|
ASH position paper: Treatment of hypertension in patients with diabetes - An update.
Journal of Clinical Hypertension.
10:707-713.
2008
|
|
| 2008
|
Hypertension in women.
International Journal of Atherosclerosis.
3:138-145.
2008
|
|
| 2008
|
Management of older hypertensive patients
2008
|
|
| 2008
|
More focus on therapeutic targets and improved tolerability in hypertension.
2008
|
|
| 2008
|
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patients.
Journal of Clinical Hypertension.
10:911-921.
2008
|
|
| 2008
|
Renin Inhibitors: Novel Agents for Renoprotection or a Better Angiotensin Receptor Blocker for Blood Pressure Lowering?.
Cardiology Clinics.
26:527-535.
2008
|
|
| 2008
|
Role of oxygen availability in CFTR expression and function.
American Journal of Respiratory Cell and Molecular Biology.
39:514-521.
2008
|
|
| 2008
|
Renin inhibition: Should it supplant ACE inhibitors and ARBS in high risk patients?.
Current Opinion in Nephrology and Hypertension.
17:484-490.
2008
|
|
| 2008
|
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension
2008
|
|
| 2008
|
Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: A losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
Hypertension.
52:279-286.
2008
|
|
| 2008
|
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET
2008
|
|
| 2008
|
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessment
2008
|
|
| 2008
|
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury
2008
|
|
| 2008
|
Thiazide-induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute.
Hypertension.
52:30-36.
2008
|
|
| 2008
|
Transforming growth factor-β signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung
2008
|
|
| 2008
|
Characterization of resistant hypertension: Association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.
Archives of Internal Medicine.
168:1159-1164.
2008
|
|
| 2008
|
Achieving better blood pressure control
2008
|
|
| 2008
|
Achieving better blood pressure control.
2008
|
|
| 2008
|
Beyond brachial pressure effect..
Current Hypertension Reports.
10:213-215.
2008
|
|
| 2008
|
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
Current Medical Research and Opinion.
24:1101-1114.
2008
|
|
| 2008
|
Effects of losartan in women with hypertension and left ventricular hypertrophy: Results from the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension.
51:1103-1108.
2008
|
|
| 2008
|
Mechanisms and treatment of resistant hypertension.
Journal of Clinical Hypertension.
10:239-244.
2008
|
|
| 2008
|
Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
Circulation Research.
102:185-192.
2008
|
|
| 2008
|
Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.
Hypertension.
51:339-344.
2008
|
|
| 2008
|
Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (FcγRI)-dependent.
American Journal of Pathology.
172:22-30.
2008
|
|
| 2007
|
Ambulatory blood pressure adds to explaining benefits of AT-1 receptor blockade in the treatment of left ventricular hypertrophy
2007
|
|
| 2007
|
Hypertension and cardiovascular disease: Is arterial stiffness the heart of the matter
2007
|
|
| 2007
|
New ESH/ESC Guidelines signal progress in hypertension management
2007
|
|
| 2007
|
Blood pressure control - Slowly getting there through new strategies?
2007
|
|
| 2007
|
The role of endothelin-1 in human hypertension.
Clinical Hemorheology and Microcirculation.
37:157-178.
2007
|
|
| 2007
|
Are current guidelines optimal for treatment of blood pressure in patients with coronary artery disease?.
Current Hypertension Reports.
9:211-213.
2007
|
|
| 2007
|
Estrogen modulates TNF-α-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-β activation
2007
|
|
| 2007
|
Mechanisms and treatment of resistant hypertension.
Arquivos Brasileiros de Cardiologia.
88.
2007
|
|
| 2007
|
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed
2007
|
|
| 2007
|
Aliskiren and valsartan for antihypertensive therapy.
ACC Cardiosource Review Journal.
16:68.
2007
|
|
| 2007
|
The ALLHAT study revisited: do newer data from this trial and others indicate changes in treatment guidelines?.
Journal of Clinical Hypertension.
9:372-380.
2007
|
|
| 2007
|
Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention.
Circulation.
115:2761-2788.
2007
|
|
| 2007
|
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update.
Circulation.
115:1481-1501.
2007
|
|
| 2007
|
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current Medical Research and Opinion.
23:259-270.
2007
|
|
| 2007
|
ANP signaling inhibits TGF-β-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells
2007
|
|
| 2007
|
Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension..
Journal of Clinical Hypertension.
9:187-195.
2007
|
|
| 2007
|
Renin inhibitors in the management of hypertension..
Journal of Clinical Hypertension.
9:706-707.
2007
|
|
| 2006
|
Beta-blockers as sub-optimal treatment for hypertension: Time for first-line therapy revision?
2006
|
|
| 2006
|
The question of whether diabetes and its cardiovascular risks can be prevented: A realistic DREAM?
2006
|
|
| 2006
|
Is there a new treatment for hypertensive disease in the horizon? Role of soluble guanylate cyclase.
Hypertension.
48:822-823.
2006
|
|
| 2006
|
Women and hypertension: What did we learn from the Women's Health Initiative?.
Cardiology in Review.
14:267-275.
2006
|
|
| 2006
|
Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.
Atherosclerosis.
188:292-300.
2006
|
|
| 2006
|
Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Clinical and Experimental Pharmacology and Physiology.
33:773-779.
2006
|
|
| 2006
|
Pulsology rediscovered: Commentary on the Conduit Artery Function Evaluation (CAFE) study.
Circulation.
113:1162-1163.
2006
|
|
| 2006
|
Dominant negative mutation of the TGF-β eceptor blocks hypoxia-induced pulmonary vascular remodeling
2006
|
|
| 2006
|
American Society of Hypertension, Inc
Leadership Message.
Journal of Clinical Hypertension.
8:904-905.
2006
|
|
| 2006
|
Efficacy and Safety of Irbesartan/HCTZ Combination Therapy As Initial Treatment for Rapid Control of Severe Hypertension.
Journal of Clinical Hypertension.
8:850-859.
2006
|
|
| 2006
|
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)..
Journal of Clinical Hypertension.
8.
2006
|
|
| 2006
|
Metabolite ligands of estrogen receptor-β reduce primate coronary hyperreactivity
2006
|
|
| 2006
|
Treatment of isolated systolic hypertension in diabetes mellitus type 2
2006
|
|
| 2005
|
Hypertension.
Hypertension.
2005
|
|
| 2005
|
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Expert Opinion on Emerging Drugs.
10:729-745.
2005
|
|
| 2005
|
Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice
2005
|
|
| 2005
|
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: The LIFE (Losartan Intervention for Endpoint reduction in hypertension) study.
Circulation.
111:1924-1931.
2005
|
|
| 2005
|
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension.
45:580-585.
2005
|
|
| 2005
|
Fixed-dose combinations in the management of hypertension: Defining the place of angiotensin receptor antagonists and hydrochlorothiazide.
American Journal of Cardiovascular Drugs.
5:17-22.
2005
|
|
| 2005
|
Conflicting and confusing data from the hypertension treatment trials: whom and what should you believe?.
Journal of Clinical Hypertension.
7:403-408.
2005
|
|
| 2005
|
Ethnicity and blood pressure..
Journal of Clinical Hypertension.
7:357-364.
2005
|
|
| 2005
|
Gender and blood pressure..
Journal of Clinical Hypertension.
7:300-309.
2005
|
|
| 2005
|
New-onset diabetes in treated hypertensive patients--is it clinically significant? Roundtable discussion..
Journal of Clinical Hypertension.
7:90-95.
2005
|
|
| 2005
|
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study.
Hypertension.
45:198-202.
2005
|
|
| 2005
|
Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals.
American Journal of Hypertension.
18:287-294.
2005
|
|
| 2005
|
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention for Endpoint reduction in hypertension study.
Hypertension.
45:46-52.
2005
|
|
| 2005
|
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study..
Journal of Clinical Hypertension.
7:152-158.
2005
|
|
| 2004
|
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: The LIFE study
2004
|
|
| 2004
|
Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling.
Hypertension.
44:746-750.
2004
|
|
| 2004
|
Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells
2004
|
|
| 2004
|
Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries.
Circulation.
110:1664-1669.
2004
|
|
| 2004
|
Hypertensive therapy: Part I.
Circulation.
109:2953-2958.
2004
|
|
| 2004
|
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
2004
|
|
| 2004
|
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
2004
|
|
| 2004
|
Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse.
Cardiovascular Research.
61:771-779.
2004
|
|
| 2004
|
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.
Circulation.
109:672-693.
2004
|
|
| 2004
|
Estradiol and Progestins Differentially Modulate Leukocyte Infiltration after Vascular Injury.
Circulation.
109:234-241.
2004
|
|
| 2004
|
Advanced glycation end-product cross-link breakers: A novel approach to cardiovascular pathologies related to the aging process.
American Journal of Hypertension.
17:S23-S30.
2004
|
|
| 2004
|
Essential hypertension in women
2004
|
|
| 2004
|
Hypertensive therapy: Part II..
Circulation.
109:3081-3088.
2004
|
|
| 2004
|
Interview with Suzanne Oparil, MD. Interview by Marvin Moser, MD..
Journal of Clinical Hypertension.
6:509-512.
2004
|
|
| 2004
|
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade..
Journal of Clinical Hypertension.
6:699-705.
2004
|
|
| 2003
|
Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study.
Annals of Internal Medicine.
139.
2003
|
|
| 2003
|
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension.
42:1206-1252.
2003
|
|
| 2003
|
Pathogenesis of Hypertension.
Annals of Internal Medicine.
139:761-776.
2003
|
|
| 2003
|
Hormone replacement therapy and inflammation: Interactions in cardiovascular disease.
Hypertension.
42:657-663.
2003
|
|
| 2003
|
Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial.
Annals of Internal Medicine.
139.
2003
|
|
| 2003
|
Fibroblast growth factor mediates hypoxia-induced endothelin-A receptor expression in lung artery smooth muscle cells
2003
|
|
| 2003
|
Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.
Hypertension.
42:88-95.
2003
|
|
| 2003
|
The seventh report of the joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 report.
Evidence Based Eye Care.
4:179-181.
2003
|
|
| 2003
|
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
2003
|
|
| 2003
|
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical implications.
Hypertension.
41:1006-1009.
2003
|
|
| 2003
|
Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice.
Clinical and Experimental Pharmacology and Physiology.
30:343-349.
2003
|
|
| 2003
|
α2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.
Hypertension.
41:571-575.
2003
|
|
| 2003
|
Secondary prevention of coronary heart disease in women: A call to action.
Annals of Internal Medicine.
138:150-151.
2003
|
|
| 2003
|
Long-Term Safety and Efficacy of the Selective Aldosterone Blocker Eplerenone in Patients with Essential Hypertension
2003
|
|
| 2003
|
The neointimal response ot endovascular injury is increased in obese Zucker rats
2003
|
|
| 2002
|
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
2002
|
|
| 2002
|
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
2002
|
|
| 2002
|
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention For Endpoint reduction (LIFE) substudy
2002
|
|
| 2002
|
Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.
Circulation.
106:854-859.
2002
|
|
| 2002
|
Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene.
2002
|
|
| 2002
|
Hormone replacement therapy and hypertension.
Current Opinion in Nephrology and Hypertension.
11:229-235.
2002
|
|
| 2002
|
Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice.
Hypertension.
39:214-218.
2002
|
|
| 2002
|
Sex hormones and hypertension.
Cardiovascular Research.
53:688-708.
2002
|
|
| 2002
|
Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice..
Hypertension.
39:214-218.
2002
|
|
| 2002
|
Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP.
2002
|
|
| 2002
|
Are there meaningful differences between antihypertensive agents?.
Cardiology in Review.
19:1-5.
2002
|
|
| 2002
|
Are there meaningful differences in blood pressure control with current antihypertensive agents?.
American Journal of Hypertension.
15:14S-21S.
2002
|
|
| 2002
|
Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP
2002
|
|
| 2002
|
Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene
2002
|
|
| 2002
|
Do angiotensin receptor antagonists have benefits beyond blood pressure lowering?.
Current Hypertension Reports.
4:219-220.
2002
|
|
| 2002
|
Interview: Suzanne Oparil, MD.
Cardiology in Review.
19:5-6.
2002
|
|
| 2001
|
Erratum: Comparative efficacy of olmesartan, losartan, valsartan and irbesartan in the control of essential hypertension (Journal of Clinical Hypertension (2001) vol. 3(5) (283-291, 318)).
Journal of Clinical Hypertension.
3:395.
2001
|
|
| 2001
|
Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats.
2001
|
|
| 2001
|
Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: Evidence from the mouse carotid artery ligation model.
Circulation.
104:2740-2745.
2001
|
|
| 2001
|
Efficacy of perindopril in the treatment of systemic hypertension..
American Journal of Cardiology.
88:3i-12i.
2001
|
|
| 2001
|
Efficacy of perindopril in the treatment of systemic hypertension.
American Journal of Cardiology.
88:3-12.
2001
|
|
| 2001
|
The American journal of cardiology: Introduction.
American Journal of Cardiology.
88.
2001
|
|
| 2001
|
Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells.
2001
|
|
| 2001
|
Cardiovascular effects of estrogen..
American Journal of Hypertension.
14:186S-193S.
2001
|
|
| 2001
|
Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
American Journal of Cardiology.
87:721-726.
2001
|
|
| 2001
|
Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.
Circulation.
103:1012-1016.
2001
|
|
| 2001
|
Hormone replacement therapy and stroke: Are the results surprising?.
Circulation.
103:620-622.
2001
|
|
| 2001
|
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.
Journal of Clinical Hypertension.
3.
2001
|
|
| 2001
|
Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs.
Current Hypertension Reports.
3:227-228.
2001
|
|
| 2001
|
Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats
2001
|
|
| 2001
|
Health outcomes associated with calcium antagonists.
Current Hypertension Reports.
3:228-229.
2001
|
|
| 2001
|
Hypertension. Introduction..
American Journal of Cardiology.
88.
2001
|
|
| 2001
|
Primary aldosteronism: A practical approach to diagnosis and treatment.
Journal of Clinical Hypertension.
3:189-195.
2001
|
|
| 2001
|
Treating hypertension in the elderly - Whom to treat, when, and with what?.
Journal of Clinical Hypertension.
3:103-109.
2001
|
|
| 2001
|
Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells
2001
|
|
| 2000
|
Endothelin and pulmonary hypertension.
Journal of Cardiovascular Pharmacology.
35.
2000
|
|
| 2000
|
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (Benazepril) with calcium antagonist (Either Nifedipine or Amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
American Journal of Cardiology.
86:1182-1187.
2000
|
|
| 2000
|
Factors affecting blood pressure responses to diet: The vanguard study.
American Journal of Hypertension.
13:956-965.
2000
|
|
| 2000
|
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The life study.
American Journal of Hypertension.
13:899-906.
2000
|
|
| 2000
|
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint..
American Journal of Hypertension.
13:899-906.
2000
|
|
| 2000
|
A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients impact on cardiovascular risk reduction.
Archives of Internal Medicine.
160:2150-2158.
2000
|
|
| 2000
|
Estrogen attenuates integrin-β3-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.
Circulation.
101:2949-2955.
2000
|
|
| 2000
|
Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group..
Academic Emergency Medicine.
7:653-662.
2000
|
|
| 2000
|
Estrogen-induced vasoprotection is estrogen receptor dependent: Evidence from the balloon-injured rat carotid artery model.
Circulation.
101:2342-2344.
2000
|
|
| 2000
|
Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery.
American Journal of Cardiology.
85:1276-1279.
2000
|
|
| 2000
|
Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.
Circulation.
101:1362-1365.
2000
|
|
| 2000
|
Essential hypertension part II: Treatment.
Circulation.
101:446-453.
2000
|
|
| 2000
|
Essential hypertension. Part I: Definition and etiology.
Circulation.
101:329-335.
2000
|
|
| 2000
|
Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure?.
Current Hypertension Reports.
2:291-294.
2000
|
|
| 2000
|
Calcium antagonists in cardiovascular disease: Clinical evidence from morbidity and mortality trials.
Drugs.
59:25-37.
2000
|
|
| 2000
|
Endothelial dysfunction in the pulmonary vascular bed.
American Journal of the Medical Sciences.
320:223-232.
2000
|
|
| 2000
|
Endothelin and pulmonary hypertension..
Journal of Cardiovascular Pharmacology.
35:S49-S53.
2000
|
|
| 2000
|
Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial.
Academic Emergency Medicine.
7:653-662.
2000
|
|
| 2000
|
Newly emerging pharmacologic differences in angiotensin II receptor blockers.
American Journal of Hypertension.
13.
2000
|
|
| 2000
|
Newly emerging pharmacologic differences in angiotensin II receptor blockers..
American Journal of Hypertension.
13:18S-24S.
2000
|
|
| 1999
|
Bradykinin in the heart: Friend or foe?.
Circulation.
100:2305-2307.
1999
|
|
| 1999
|
Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries.
Cardiovascular Research.
44:608-614.
1999
|
|
| 1999
|
Harriet Pearson Dustan..
Circulation.
100:2122-2123.
1999
|
|
| 1999
|
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension..
American Journal of Cardiology.
84:35S-41S.
1999
|
|
| 1999
|
Treating multiple-risk hypertensive populations..
American Journal of Hypertension.
12:121S-129S.
1999
|
|
| 1999
|
Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.
Circulation.
100:1639-1645.
1999
|
|
| 1999
|
Effects of candesartan cilexetil in patients with severe systemic hypertension.
American Journal of Cardiology.
84:289-293.
1999
|
|
| 1999
|
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators..
American Journal of Cardiology.
84:289-293.
1999
|
|
| 1999
|
Fenoldopam: A new parenteral antihypertensive: Consensus roundtable on the management of perioperative hypertension and hypertensive crises.
American Journal of Hypertension.
12:653-664.
1999
|
|
| 1999
|
Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.
Circulation.
99:2583-2589.
1999
|
|
| 1999
|
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement..
Circulation.
99:2480-2484.
1999
|
|
| 1999
|
Guide to preventive cardiology for women.
Circulation.
99:2480-2484.
1999
|
|
| 1999
|
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
American Journal of Hypertension.
12:414-417.
1999
|
|
| 1999
|
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension..
American Journal of Hypertension.
12:414-417.
1999
|
|
| 1999
|
Journal of Cardiovascular Pharmacology: Introduction.
Journal of Cardiovascular Pharmacology.
33.
1999
|
|
| 1999
|
Long-term morbidity and mortality trials with amlodipine.
Journal of Cardiovascular Pharmacology.
33.
1999
|
|
| 1999
|
Management of the hypertensive patient with coronary artery disease..
American Journal of Hypertension.
12:56S-62S.
1999
|
|
| 1999
|
Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes.
Diabetes Care.
22:191-197.
1999
|
|
| 1999
|
Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection..
Hypertension.
33:170-176.
1999
|
|
| 1999
|
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension..
American Journal of Cardiology.
84:35-41.
1999
|
|
| 1999
|
Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: Evaluation from a 12-week prospective, open-label clinical trial in community-based clinics.
American Journal of Therapeutics.
6:19-24.
1999
|
|
| 1999
|
Comparison of telmisartan with lisinopril in patients with mild-to- moderate hypertension.
American Journal of Therapeutics.
6:161-166.
1999
|
|
| 1999
|
Eprosartan versus enalapril in hypertensive patients with angiotensin- converting enzyme inhibitor-induced cough
1999
|
|
| 1999
|
Hypertension in women.
Journal of Clinical Endocrinology and Metabolism.
84:1862-1866.
1999
|
|
| 1999
|
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
American Journal of Clinical Nutrition.
70:881-887.
1999
|
|
| 1999
|
Management of the hypertensive patient with coronary artery disease.
American Journal of Hypertension.
12:56S-62S.
1999
|
|
| 1999
|
Nontraditional cardiovascular risk factors.
American Journal of the Medical Sciences.
317:193-207.
1999
|
|
| 1999
|
Recent outcome trials of newer antihypertensives.
Current Hypertension Reports.
1:238-240.
1999
|
|
| 1999
|
Treating multiple-risk hypertensive populations.
American Journal of Hypertension.
12:121-129.
1999
|
|
| 1998
|
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension..
Hypertension.
32:989-997.
1998
|
|
| 1998
|
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case study..
American Journal of Hypertension.
11:192S-194S.
1998
|
|
| 1998
|
Effects of Candesartan cilexetil in patients with systemic hypertension.
American Journal of Cardiology.
82:961-965.
1998
|
|
| 1998
|
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators..
American Journal of Cardiology.
82:961-965.
1998
|
|
| 1998
|
Garlic prevents hypoxic pulmonary hypertension in rats..
American Journal of Physiology.
275:L283-L287.
1998
|
|
| 1998
|
Pathophysiology of sudden coronary death in women: Implications for prevention.
Circulation.
97:2103-2105.
1998
|
|
| 1998
|
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
1998
|
|
| 1998
|
Antihypertensive treatment in postmenopausal women: Results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (Moexipril) with a diuretic (Hydrochlorothiazide)
1998
|
|
| 1998
|
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension..
American Journal of Hypertension.
11:88S-94S.
1998
|
|
| 1998
|
Managing the patient with hard-to-control hypertension.
American Family Physician.
57:1007-1014.
1998
|
|
| 1998
|
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan
1998
|
|
| 1998
|
Case study.
American Journal of Hypertension.
11.
1998
|
|
| 1998
|
Characteristics of 9194 patients with left ventricular hypertrophy: The LIFE study.
Hypertension.
32:989-997.
1998
|
|
| 1998
|
Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension.
American Journal of Hypertension.
11:31-40.
1998
|
|
| 1998
|
Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension..
American Journal of Hypertension.
11:31-40.
1998
|
|
| 1998
|
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker
1998
|
|
| 1998
|
Garlic prevents hypoxic pulmonary hypertension in rats
1998
|
|
| 1998
|
Healthier diets improve quality of life while reducing cardiovascular disease risk factors.
Disease Management and Clinical Outcomes.
1:106-113.
1998
|
|
| 1998
|
Mibefradil, a T-channel-selective calcium antagonist: Clinical trials in hypertension.
American Journal of Hypertension.
11:88S-94S.
1998
|
|
| 1998
|
The sexual dimorphism of high blood pressure.
Cardiology in Review.
6:356-363.
1998
|
|
| 1997
|
No role for NO in estrogen-mediated vasoprotection?.
Circulation.
96:2769-2771.
1997
|
|
| 1997
|
High blood pressure in women
1997
|
|
| 1997
|
Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations..
American Journal of Physiology.
273:H1769-H1774.
1997
|
|
| 1997
|
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice..
American Journal of Physiology.
273:L848-L855.
1997
|
|
| 1997
|
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs
1997
|
|
| 1997
|
A 42-year-old man with hypertension
1997
|
|
| 1997
|
Estrogen restores endothelial cell function in an experimental model of vascular injury.
Circulation.
96:1624-1630.
1997
|
|
| 1997
|
Antihypertensive effects of mibefradil in the treatment of mild-to- moderate systemic hypertension.
American Journal of Cardiology.
80.
1997
|
|
| 1997
|
Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension..
American Journal of Cardiology.
80:12C-19C.
1997
|
|
| 1997
|
Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension.
American Journal of Hypertension.
10:735-742.
1997
|
|
| 1997
|
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs..
American Journal of Physiology.
273:H961-H970.
1997
|
|
| 1997
|
Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function..
Hypertension.
30:128-133.
1997
|
|
| 1997
|
Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension..
American Journal of Hypertension.
10:735-742.
1997
|
|
| 1997
|
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group..
American Journal of Hypertension.
10:705-713.
1997
|
|
| 1997
|
The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Journal of Cardiovascular Pharmacology.
29:713-725.
1997
|
|
| 1997
|
ALLHAT and calcium channel blockers [3].
American Journal of Hypertension.
10:142-143.
1997
|
|
| 1997
|
ALLHAT and calcium channel blockers. ALLHAT Research Group..
American Journal of Hypertension.
10:142-143.
1997
|
|
| 1997
|
Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
1997
|
|
| 1997
|
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients.
American Journal of Hypertension.
10:68-76.
1997
|
|
| 1997
|
Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function.
Hypertension.
30:128-133.
1997
|
|
| 1997
|
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet.
American Journal of Clinical Nutrition.
66:373-385.
1997
|
|
| 1997
|
Erratum: Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (American Journal of Hypertension (July 1997) 10 (735-742)).
American Journal of Hypertension.
10:1081.
1997
|
|
| 1997
|
Fenoldopam: A novel, peripherally acting dopamine-1 agonist for parenteral treatment of hypertension.
Drugs of Today.
33:729-738.
1997
|
|
| 1997
|
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice
1997
|
|
| 1997
|
Nutritional management of cardiovascular risk factors: A randomized clinical trial.
Archives of Internal Medicine.
157:169-177.
1997
|
|
| 1997
|
Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment.
Circulation.
95:1301-1307.
1997
|
|
| 1997
|
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study rationale, design, and methods.
American Journal of Hypertension.
10:705-713.
1997
|
|
| 1997
|
The expanding role of calcium antagonists in cardiovascular disease
1997
|
|
| 1997
|
Tolerability profile of tasosartan, a long-acting angiotensin II AT1 receptor blocker, in the treatment of patients with essential hypertension
1997
|
|
| 1997
|
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs
1997
|
|
| 1996
|
White Coat Hypertension???Fact or Fancy?.
American Journal of the Medical Sciences.
312:219-220.
1996
|
|
| 1996
|
Purification and assay methods for angiotensin-converting enzyme
1996
|
|
| 1996
|
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology..
Cardio-vascular nursing.
32:26-28.
1996
|
|
| 1996
|
Antihypertensive therapy in the era of evidence based medical practice: What to do until the facts are in.
Current Opinion in Nephrology and Hypertension.
5:159-161.
1996
|
|
| 1996
|
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group..
American Journal of Hypertension.
9:342-360.
1996
|
|
| 1996
|
Acute saline infusion decreases norepinephrine release in the anterior hypothalamic area..
Hypertension.
27:578-583.
1996
|
|
| 1996
|
Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.
Circulation.
93:577-584.
1996
|
|
| 1996
|
Anterior hypothalamic norepinephrine, atrial natriuretic peptide, and hypertension.
Frontiers in Neuroendocrinology.
17:212-246.
1996
|
|
| 1996
|
Antihypertensive therapy and atherosclerosis in coronary heart disease.
Cardiovascular Risk Factors.
6:222-232.
1996
|
|
| 1996
|
Atrial natriuretic peptide blunts arterial baroreflex in spontaneously hypertensive rats.
Hypertension.
27:297-302.
1996
|
|
| 1996
|
Cardiac renin angiotensin system in hypertrophy and the progression to heart failure.
Heart Failure Reviews.
1:63-72.
1996
|
|
| 1996
|
Classic papers symposium of the southern clinical research meetings: White coat hypertension - Fact or fancy?.
American Journal of the Medical Sciences.
312:219-220.
1996
|
|
| 1996
|
Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension
1996
|
|
| 1996
|
Hypertension: Initial evaluation.
ACC Current Journal Review.
5:60-62.
1996
|
|
| 1996
|
Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared diet.
American Journal of Clinical Nutrition.
64:935-943.
1996
|
|
| 1996
|
Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery.
Circulation.
94:2221-2227.
1996
|
|
| 1996
|
Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT).
American Journal of Hypertension.
9:342-360.
1996
|
|
| 1996
|
Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension.
Hypertension.
28:335-340.
1996
|
|
| 1996
|
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
1996
|
|
| 1995
|
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation..
American Journal of Physiology.
269:H2065-H2073.
1995
|
|
| 1995
|
ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat..
American Journal of Physiology.
269:L690-L697.
1995
|
|
| 1995
|
Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue.
Biochemical Pharmacology.
50:1445-1450.
1995
|
|
| 1995
|
Hypertension in postmenopausal women: Pathophysiology and management.
Current Opinion in Nephrology and Hypertension.
4:438-442.
1995
|
|
| 1995
|
Calcium antagonists: Antihypertensive and vascular considerations
1995
|
|
| 1995
|
Acute hypertension increases norepinephrine release in the anterior hypothalamic area..
Hypertension.
25:828-833.
1995
|
|
| 1995
|
Cardiovascular health at the crossroads: outlook for the 21st century. Presented at the 67th Scientific Sessions of the American Heart Association November 4, 1994 Dallas, Texas..
Circulation.
91:1304-1310.
1995
|
|
| 1995
|
Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia..
American Journal of Physiology.
268:L328-L335.
1995
|
|
| 1995
|
ET(A)-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat
1995
|
|
| 1995
|
Effect of amlodipine on left ventricular mass in the amlodipine cardiovascular community trial.
Journal of Cardiovascular Pharmacology.
26:471-476.
1995
|
|
| 1995
|
Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat
1995
|
|
| 1995
|
Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat..
American Journal of Physiology.
268:L95-100.
1995
|
|
| 1995
|
Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
1995
|
|
| 1995
|
Fighting the NIH funding crisis.
Circulation.
91:2502.
1995
|
|
| 1995
|
Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats.
Hypertension.
26:285-289.
1995
|
|
| 1995
|
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation
1995
|
|
| 1995
|
Preventing heart attack and death in patients with coronary disease.
Circulation.
92:2-4.
1995
|
|
| 1995
|
Racial differences in the pathogenesis of hypertension.
American Journal of the Medical Sciences.
310.
1995
|
|
| 1995
|
SSCI founders medal recipient's address.
American Journal of the Medical Sciences.
310:4-5.
1995
|
|
| 1995
|
Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia
1995
|
|
| 1994
|
Increased endothelin receptor gene expression in hypoxic rat lung..
American Journal of Physiology.
266:L553-L560.
1994
|
|
| 1994
|
Antihypertensive therapy in the context of total cardiovascular risk: the rational basis for therapeutic recommendations..
Current Opinion in Nephrology and Hypertension.
3:195-199.
1994
|
|
| 1994
|
Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats.
Hypertension.
24:1-7.
1994
|
|
| 1994
|
Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia
1994
|
|
| 1994
|
Increased endothelin receptor gene expression in hypoxic rat lung
1994
|
|
| 1994
|
Increased endothelin receptor gene expression in hypoxic rat lung
1994
|
|
| 1994
|
Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.
Circulation.
90:2468-2473.
1994
|
|
| 1994
|
Role of anterior hypothalamic angiotensin II in the pathogenesis of salt sensitive hypertension in the spontaneously hypertensive rat.
American Journal of the Medical Sciences.
307.
1994
|
|
| 1994
|
Sodium-proton (Na+/H+) exchange inhibition increases blood pressure in spontaneously hypertensive rat.
American Journal of the Medical Sciences.
308:145-151.
1994
|
|
| 1993
|
Report of the task force on children and youth. American Heart Association..
Circulation.
88:2479-2486.
1993
|
|
| 1993
|
Simplified method for quantitation of angiotensin peptides in tissue.
Journal of Chromatography - Biomedical Applications.
614:19-25.
1993
|
|
| 1993
|
Coarctation induces alterations in basement membranes in the cardiovascular system.
Hypertension.
22:743-753.
1993
|
|
| 1993
|
Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats.
Hypertension.
22:285-291.
1993
|
|
| 1993
|
Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat.
Hypertension.
21:185-194.
1993
|
|
| 1993
|
Normotensive blacks have heightened sympathetic response to cold pressor test.
Hypertension.
22:801-805.
1993
|
|
| 1993
|
Presentation of the Southern Society for Clinical Investigation Founder's Medal to Dr. James A. Pittman, Jr..
American Journal of the Medical Sciences.
306:1-3.
1993
|
|
| 1993
|
Report of the task force on children and youth.
Circulation.
88:2479-2485.
1993
|
|
| 1992
|
Normobaric hypoxia stimulates endothelin-1 gene expression in the rat..
American Journal of Physiology.
263:R1260-R1264.
1992
|
|
| 1992
|
Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells..
American Journal of Physiology.
263:C743-C749.
1992
|
|
| 1992
|
Preparative isolation of angiotensin-converting enzyme from human lung.
Journal of Chromatography - Biomedical Applications.
579:63-71.
1992
|
|
| 1992
|
Isolation of two distinct type I angiotensin II receptor genes.
Biochemical and Biophysical Research Communications.
184:1067-1073.
1992
|
|
| 1992
|
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats..
American Journal of Hypertension.
5:210-218.
1992
|
|
| 1992
|
Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats.
Hypertension.
19:456-463.
1992
|
|
| 1992
|
Atrial natriuretic peptide modulates baroreceptor reflex in spontaneously hypertensive rat.
Hypertension.
20:374-379.
1992
|
|
| 1992
|
Blocking hypothalamic AT1 receptors lowers blood pressure in salt- sensitive rats.
Hypertension.
20:755-762.
1992
|
|
| 1992
|
Cicletanine blunts the pulmonary pressor response to acute hypoxia in rats.
American Journal of the Medical Sciences.
304:14-19.
1992
|
|
| 1992
|
Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
American Journal of Physiology.
263.
1992
|
|
| 1992
|
Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.
Hypertension.
19:475-481.
1992
|
|
| 1992
|
Effects of acute and chronic blockade of neutral endopeptidase with sch 34826 on nacl-sensitive hypertension in spontaneously hypertensive rats.
American Journal of Hypertension.
5:210-218.
1992
|
|
| 1992
|
Ganglion atrial natriuretic peptide in nacl sensitive spontaneously hypertensive rats.
American Journal of Hypertension.
5:806-810.
1992
|
|
| 1992
|
Neuronal control of the kidney: Contribution to hypertension.
Canadian Journal of Physiology and Pharmacology.
70:759-770.
1992
|
|
| 1992
|
Normobaric hypoxia stimulates endothelin-1 gene expression in the rat.
American Journal of Physiology.
263.
1992
|
|
| 1992
|
Preparative isolation of angiotensin-converting enzyme from human lung.
Journal of Chromatography - Biomedical Applications.
579:63-71.
1992
|
|
| 1992
|
Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.
Hypertension.
19:198-205.
1992
|
|
| 1992
|
Quantitation of hypothalamic atrial natriuretic peptide messenger RNA in hypertensive rats.
Hypertension.
19:296-300.
1992
|
|
| 1992
|
Salt supplementation does not alter the pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.
Hypertension.
20:242-246.
1992
|
|
| 1992
|
Spontaneously hypertensive rat: Lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation.
American Journal of Physiology.
262.
1992
|
|
| 1992
|
Spontaneously hypertensive rat: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation..
American Journal of Physiology.
262:R1-R7.
1992
|
|
| 1991
|
Decreased norepinephrine release in anterior hypothalamus of NaCl-sensitive spontaneously hypertensive rats during high NaCl intake.
Brain Research.
565:135-141.
1991
|
|
| 1991
|
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats via sympatholytic and renal effects.
American Journal of Clinical Nutrition.
54.
1991
|
|
| 1991
|
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats via sympatholytic and renal effects..
American Journal of Clinical Nutrition.
54:227S-236S.
1991
|
|
| 1991
|
The calcium antagonists in the 1990s. An overview..
American Journal of Hypertension.
4:396S-405S.
1991
|
|
| 1991
|
Altered stores of atrial natriuretic peptide in specific brain nuclei of NaCl-sensitive spontaneously hypertensive rats..
American Journal of Hypertension.
4:449-455.
1991
|
|
| 1991
|
Altered stores of atrial natriuretic peptide in specific brain nuclei of nacl-sensitive spontaneously hypertensive rats.
American Journal of Hypertension.
4:449-455.
1991
|
|
| 1991
|
Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension.
American Journal of the Medical Sciences.
301:383-389.
1991
|
|
| 1991
|
Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats
1991
|
|
| 1991
|
High NaCl diet enhances arterial baroreceptor reflex in NaCl-sensitive spontaneously hypertensive rats.
Hypertension.
17:363-368.
1991
|
|
| 1991
|
Intrahypothalamic clonidine infusion prevents NaCl-sensitive hypertension.
Hypertension.
18:224-229.
1991
|
|
| 1991
|
The calcium antagonists in the 1990s an overview.
American Journal of Hypertension.
4:396S-405S.
1991
|
|
| 1990
|
In Reply
1990
|
|
| 1990
|
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats by a sympatholytic mechanism..
American Journal of Hypertension.
3:179S-188S.
1990
|
|
| 1990
|
High-performance liquid chromatographic determination of amiloride and its analogues in rat plasma..
J Chromatogr.
529:201-209.
1990
|
|
| 1990
|
An Assessment of Diltiazem and Hydrochlorothiazide in Hypertension
1990
|
|
| 1990
|
An Assessment of Diltiazem and Hydrochlorothiazide in Hypertension: Application of Factorial Trial Design to a Multicenter Clinical Trial of Combination Therapy
1990
|
|
| 1990
|
Vascular effects of kinins in trout and bradykinin metabolism by perfused gill..
American Journal of Physiology.
258:R515-R522.
1990
|
|
| 1990
|
Atrial natriuretic factor prevents NaCl-sensitive hypertension in spontaneously hypertensive rats.
Hypertension.
15:170-176.
1990
|
|
| 1990
|
Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats
1990
|
|
| 1990
|
Changes in cerebrospinal fluid Na+ concentration do not underlie hypertensive responses to dietary NaCl in spontaneously hypertensive rats.
Brain Research.
506:149-152.
1990
|
|
| 1990
|
Dietary ca2+prevents NaCl-sensitive hypertension in spontaneously hypertensive rats by a sympatholytic mechanism.
American Journal of Hypertension.
3:179S-188S.
1990
|
|
| 1990
|
High-performance liquid chromatographic determination of amiloride and its analogues in rat plasma.
Journal of Chromatography - Biomedical Applications.
529:201-209.
1990
|
|
| 1990
|
Interleukin-2 does not attenuate hypertension in spontaneously hypertensive rats.
Hypertension.
16:468-471.
1990
|
|
| 1990
|
NaCl does not affect hypothalamic noradrenergic input in deoxycorticosterone acetate/NaCl and dahl salt-sensitive rats.
Hypertension.
16:55-62.
1990
|
|
| 1990
|
Noninvasive Assessment of Renal Artery Stenosis by Combined Conventional and Color Doppler Ultrasound
1990
|
|
| 1990
|
Vascular effects of kinins in trout and bradykinin metabolism by perfused gill.
American Journal of Physiology.
258.
1990
|
|
| 1989
|
Central mechanisms of hypertension..
American Journal of Hypertension.
2:477-485.
1989
|
|
| 1989
|
Dietary NaCl loading enhances antihypertensive effect of guanabenz in spontaneously hypertensive rats..
American Journal of Hypertension.
2:435-439.
1989
|
|
| 1989
|
Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis..
American Journal of Physiology.
256:C1231-C1238.
1989
|
|
| 1989
|
Atrial natriuretic factor in NaCl-sensitive and NaCl-resistant spontaneously hypertensive rats.
Hypertension.
14:404-412.
1989
|
|
| 1989
|
Atrial natriuretic peptide lowers pulmonary arterial pressure in patients with high altitude disease.
American Journal of the Medical Sciences.
298:397-401.
1989
|
|
| 1989
|
Central mechanisms of hypertension.
American Journal of Hypertension.
2:477-485.
1989
|
|
| 1989
|
Dietary Ca2+ supplementation prevents the exaggerated responsiveness of anterior hypothalamic α2-adrenoceptors in NaCl-loaded spontaneously hypertensive rats.
Journal of Cardiovascular Pharmacology.
13:162-167.
1989
|
|
| 1989
|
Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia
1989
|
|
| 1989
|
Hypertension.
Disease-A-Month.
35:138-232.
1989
|
|
| 1989
|
Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis.
American Journal of Physiology.
256.
1989
|
|
| 1989
|
Impaired reflex response to volume expansion in NaCl-sensitive spontaneously hypertensive rats.
Hypertension.
14:518-524.
1989
|
|
| 1989
|
Purification of angiotensin-converting enzyme by gel high-performance liquid chromatography
1989
|
|
| 1989
|
Renal nerve contribution to NaCl-exacerbated hypertension in spontaneously hypertensive rats.
Hypertension.
14:184-190.
1989
|
|
| 1989
|
Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide.
American Journal of the Medical Sciences.
298:227-236.
1989
|
|
| 1988
|
Enhanced cold pressor response in spontaneously hypertensive rats on high-NaCl diet.
American Journal of Physiology.
255.
1988
|
|
| 1988
|
Enhanced cold pressor response in spontaneously hypertensive rats on high-NaCl diet..
American Journal of Physiology.
255:H1018-H1023.
1988
|
|
| 1988
|
Treating the older hypertensive patient-an overview.
American Journal of Medicine.
85:1.
1988
|
|
| 1988
|
Effect of steric exclusion on the separation of proteins by hydrophilic size-exclusion chromatography..
J Chromatogr.
445:29-36.
1988
|
|
| 1988
|
Exaggerated depressor response to 6-iodoamiloride in NaCl-sensitive spontaneously hypertensive rats..
American Journal of the Medical Sciences.
296:78-83.
1988
|
|
| 1988
|
High NaCl diet increases anterior hypothalamic α2-adrenoceptors in SHR.
Brain Research.
451:77-84.
1988
|
|
| 1988
|
Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats..
Hypertension.
11:739-744.
1988
|
|
| 1988
|
Captopril and the response to stress in the spontaneously hypertensive rat..
Hypertension.
11:I144-I147.
1988
|
|
| 1988
|
Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats
1988
|
|
| 1988
|
Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats
1988
|
|
| 1988
|
Captopril and the response to stress in the spontaneously hypertensive rat.
Hypertension.
11:I-144-I-147.
1988
|
|
| 1988
|
Effect of steric exclusion on the separation of proteins by hydrophilic size-exclusion chromatography
1988
|
|
| 1988
|
Genetic basis of NaCl-sensitive hypertension.
Journal of Cardiovascular Pharmacology.
12:S56-S69.
1988
|
|
| 1988
|
High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats.
Hypertension.
11:55-62.
1988
|
|
| 1988
|
Hypoxia-induced oxygen tolerance: Maintenance of endothelial metabolic function.
Experimental Lung Research.
14:887-896.
1988
|
|
| 1988
|
Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats.
Hypertension.
11:739-744.
1988
|
|
| 1988
|
Perioperative red blood cell transfusion
1988
|
|
| 1988
|
Rapid communication: Exaggerated depressor response to 6-iodoamiloride in NaCl-sensitive spontaneously hypertensive rats.
American Journal of the Medical Sciences.
296:78-83.
1988
|
|
| 1988
|
The neural basis of salt sensitivity in the rat: Altered hypothalamic function.
American Journal of the Medical Sciences.
295:360-369.
1988
|
|
| 1987
|
Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
Brain Research.
413:15-22.
1987
|
|
| 1987
|
De novo intrarenal formation of angiotensin II during control and enhanced renin secretion..
American Journal of Physiology.
252:F1118-F1123.
1987
|
|
| 1987
|
Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat..
Hypertension.
9:III171-III175.
1987
|
|
| 1987
|
Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril..
American Journal of Physiology.
252:H796-H806.
1987
|
|
| 1987
|
Two renal alpha 2-adrenergic receptor sites revealed by p-aminoclonidine binding..
American Journal of Physiology.
252:F283-F290.
1987
|
|
| 1987
|
Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
Brain Research.
400:225-231.
1987
|
|
| 1987
|
Antihypertensive effect of enalapril in essential hypertension: Role of prostacyclin.
American Journal of the Medical Sciences.
294:395-402.
1987
|
|
| 1987
|
Blunted responsiveness of posterior hypothalamic norepinephrine to quinpirole in DOCA/NaCl hypertensive rats.
Brain Research Bulletin.
18:563-568.
1987
|
|
| 1987
|
De novo intrarenal formation of angiotensin II during control and enhanced renin secretion.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
252.
1987
|
|
| 1987
|
Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat.
Hypertension.
9:III-171-III-175.
1987
|
|
| 1987
|
Failure of renal denervation to attenuate hypertension in Dahl NaCl-sensitive rats.
Canadian Journal of Physiology and Pharmacology.
65:2428-2432.
1987
|
|
| 1987
|
Hyperoxia-induced converting enzyme insufficiency in conscious rat: Cardiovascular effects.
Experimental Lung Research.
12:37-56.
1987
|
|
| 1987
|
Hypertension produced by a high sodium diet in the borderline hypertensive rat (BHR).
Clinical and experimental hypertension.
A9:1713-1731.
1987
|
|
| 1987
|
Hypertension produced by a high sodium diet in the borderline hypertensive rat (BHR)..
Clinical and experimental hypertension.
9:1713-1731.
1987
|
|
| 1987
|
Hypoxia-induced inhibition of converting enzyme activity: Role in vascular regulation
1987
|
|
| 1987
|
Proteoglycans and hypertension: III: Aorta proteoglycans in Dahl salt-sensitive hypertensive rats.
American Journal of the Medical Sciences.
293:171-176.
1987
|
|
| 1987
|
Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after NaCl loading.
Hypertension.
10:313-320.
1987
|
|
| 1987
|
Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril
1987
|
|
| 1987
|
The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension.
Journal of Cardiovascular Pharmacology.
9:S43-S47.
1987
|
|
| 1987
|
The renal afferent nerves in the pathogenesis of hypertension.
Canadian Journal of Physiology and Pharmacology.
65:1548-1558.
1987
|
|
| 1987
|
Two renal α2-adrenergic receptor sites revealed by p-aminoclonidine binding.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
252.
1987
|
|
| 1987
|
Yohimbine-induced alterations of monoamine metabolism in the spontaneously hypertensive rat of the okamoto strain (SHR). II. The Central Nervous System (CNS).
Brain Research Bulletin.
19:525-534.
1987
|
|
| 1987
|
Yohimbine-induced alterations of monoamine metabolism in the spontaneously hypertensive rat. I. The peripheral nervous system.
Brain Research Bulletin.
19:101-108.
1987
|
|
| 1986
|
Transport and hydrolysis of glucagon in the proximal nephron..
American Journal of Physiology.
251:F460-F467.
1986
|
|
| 1986
|
Angiotensin extraction by trout tissues in vivo and metabolism by the perfused gill..
American Journal of Physiology.
250:R532-R538.
1986
|
|
| 1986
|
Angiotensin extraction by trout tissues in vivo and metabolism by the perfused gill
1986
|
|
| 1986
|
Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia
1986
|
|
| 1986
|
Increased vasopressinergic activity following DOCA administration in the rat.
Brain Research Bulletin.
16:93-98.
1986
|
|
| 1986
|
Sensory denervation of the kidney attenuates renovascular hypertension in the rat
1986
|
|
| 1986
|
Sensory denervation of the kidney attenuates renovascular hypertension in the rat..
American Journal of Physiology.
250:H82-H86.
1986
|
|
| 1986
|
Transport and hydrolysis of glucagon in the proximal nephron.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
251.
1986
|
|
| 1985
|
Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat
1985
|
|
| 1985
|
Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats
1985
|
|
| 1985
|
Hypertension in a 74-year-old man with hydronephrosis and coronary disease..
Hypertension.
7:824-833.
1985
|
|
| 1985
|
Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat..
American Journal of Physiology.
249.
1985
|
|
| 1985
|
Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats..
American Journal of Physiology.
249.
1985
|
|
| 1985
|
Enhanced Depressor Effect of Muscimol in the DOCA/NaCl Hypertensive Rat: Evidence for Altered GABAergic Activity in Brain
1985
|
|
| 1985
|
Hypertension in a 74-year-old man with hydronephrosis and coronary disease principal discussant.
Hypertension.
7:824-833.
1985
|
|
| 1984
|
The role of the posterior hypothalamic area in the pathogenesis of hypertension in the spontaneously hypertensive rat.
Brain Research.
324:51-58.
1984
|
|
| 1984
|
Myocardial cell hypertrophy or hyperplasia.
Hypertension.
6.
1984
|
|
| 1984
|
Renal handling of glucagon and insulin..
Contributions to Nephrology.
42:30-37.
1984
|
|
| 1984
|
Myocardial cell hypertrophy or hyperplasia..
Hypertension.
6:III38-III43.
1984
|
|
| 1984
|
Hormonal and haemodynamic responses to upper abdominal surgery during isoflurane and balanced anaesthesia.
Canadian Anaesthetists' Society journal.
31:509-516.
1984
|
|
| 1984
|
Subcellular sites of insulin hydrolysis in renal proximal tubules.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
15.
1984
|
|
| 1984
|
Elevated catecholamines during cardiac surgery: Consequences of reperfusion of the postarrested heart.
American Journal of Cardiology.
53:722-728.
1984
|
|
| 1984
|
A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.
Circulation.
69:973-982.
1984
|
|
| 1984
|
Comprehensive drug management of hypertension.
Cardiovascular clinics.
14:73-91.
1984
|
|
| 1984
|
Myocardial cell hypertrophy or hyperplasia.
Hypertension.
6:38-43.
1984
|
|
| 1984
|
Subcellular sites of insulin hydrolysis in renal proximal tubules.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
15.
1984
|
|
| 1983
|
Effect of hypoxia on the conversion of angiotensin I to II in cultured porcine pulmonary endothelial cells.
Biochemical Pharmacology.
32:1201-1205.
1983
|
|
| 1983
|
Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.
Hypertension.
5:689-700.
1983
|
|
| 1983
|
Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril.
Hypertension.
5:653-662.
1983
|
|
| 1983
|
Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat
1983
|
|
| 1983
|
Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat
1983
|
|
| 1983
|
Enalapril in low-renin essential hypertension.
Clinical Pharmacology and Therapeutics.
34:297-302.
1983
|
|
| 1983
|
Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
14.
1983
|
|
| 1983
|
Kidney function and sodium handling in the pregnant spontaneously hypertensive rat.
Hypertension.
5:498-506.
1983
|
|
| 1983
|
Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
Hypertension.
5:427-435.
1983
|
|
| 1982
|
Differences between renal tubular processing of glucagon and insulin.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
11.
1982
|
|
| 1982
|
Importance of the renal nerves in the pathogenesis of experimental hypertension..
Hypertension.
4:III108-III114.
1982
|
|
| 1982
|
The AFCR: is there life after 41?.
Clinical research.
30:316-321.
1982
|
|
| 1982
|
Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension..
Hypertension.
4:166-174.
1982
|
|
| 1982
|
Effect of hypoxia on the conversion of angiotensin I to II in the isolated perfused rat lung.
Biochemical Pharmacology.
31:1375-1379.
1982
|
|
| 1982
|
1982: A critical year for hypertension.
Hypertension.
4:1-2.
1982
|
|
| 1982
|
Central effects of prostaglandin E2 on blood pressure and plasma renin activity in rats role of the sympathoadrenal system and vasopressin.
Hypertension.
4:809-816.
1982
|
|
| 1982
|
Central sympathectomy with 6-hydroxydopamine prevents DOCA/NaCl hypertension by mechanisms independent of vasopressin.
Clinical research.
30.
1982
|
|
| 1982
|
Decrease in hypothalamic norepinephrine content following renal denervation in the one-kidney, one clip goldblatt hypertensive rat.
Hypertension.
4:369-373.
1982
|
|
| 1982
|
Decrease in sympathetic nervous system activity and attenuation in response to stress following renal denervation in the one-kidney one-clip Goldblatt hypertensive rat..
Clinical and experimental hypertension.
4:707-716.
1982
|
|
| 1982
|
Decrease in sympathetic nervous system activity and attenuation in response to stress following renal denervation in the one-kidney one-clip goldblatt hypertensive rat.
Clinical and experimental hypertension.
A4:707-716.
1982
|
|
| 1982
|
Differences between renal tubular processing of glucagon and insulin.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
11.
1982
|
|
| 1982
|
Importance of the renal Nerves in the Pathogenesis of Experimental Hypertension.
Hypertension.
4:108-115.
1982
|
|
| 1982
|
Importance of the renal nerves in established Two-Kidney, one clip goldblatt hypertension.
Hypertension.
4:166-174.
1982
|
|
| 1982
|
Increased noradrenaline content of hypothalamic nuclei in association with worsening of hypertension after high sodium intake in the young spontaneously hypertensive rat.
Clinical Science.
63.
1982
|
|
| 1982
|
Increased noradrenergic activity in hypothalamic nuclei of spontaneously hypertensive rats on high sodium intake.
Clinical research.
30.
1982
|
|
| 1982
|
Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man.
Circulation.
66:49-55.
1982
|
|
| 1982
|
Prevention of hypertension in the spontaneously hypertensive rat by chronic central administration of captopril.
Clinical research.
30.
1982
|
|
| 1982
|
Review of therapeutic modalities acting directly via central pathways.
Clinical and experimental hypertension.
A4:579-593.
1982
|
|
| 1982
|
Review of therapeutic modalities acting directly via central pathways..
Clinical and experimental hypertension.
4:579-593.
1982
|
|
| 1982
|
Sodium-neural interactions in the development of spontaneous hypertension.
Clinical and experimental hypertension.
A4:751-760.
1982
|
|
| 1982
|
Sodium-neural interactions in the development of spontaneous hypertension..
Clinical and experimental hypertension.
4:751-760.
1982
|
|
| 1982
|
The role of calcium in the control of renin release.
Hypertension.
4:670-675.
1982
|
|
| 1981
|
A progress report on hypertension.
Hypertension.
3:1-3.
1981
|
|
| 1981
|
Catecholamine changes during cardiopulmonary bypass: The stress response and role of the lungs in modulating it.
Anesthesia and Analgesia.
60:272-273.
1981
|
|
| 1981
|
Central effects of prostaglandin E2 on blood pressure and plasma renin activity: Role of the sympathoadrenal system and vasopressin.
Clinical research.
29.
1981
|
|
| 1981
|
Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report..
Critical Care Medicine.
9:651-654.
1981
|
|
| 1981
|
Effects of sodium intake and Goldblatt hypertension on renin release in rat kidney slices.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
9.
1981
|
|
| 1981
|
Effects of sodium intake and Goldblatt hypertension on renin release in rat kidney slices.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
9.
1981
|
|
| 1981
|
Hypertension and oral contraceptives.
Journal of Cardiovascular Medicine.
6:381-387.
1981
|
|
| 1981
|
Lofexidine and clonidine in moderate essential hypertension.
Clinical Pharmacology and Therapeutics.
30:752-757.
1981
|
|
| 1981
|
Prevention of DOCA/NaCl hypertension in the rat by central sympatholytic treatment is unrelated to vasopressin.
Clinical research.
29.
1981
|
|
| 1981
|
Renal function during reflexly activated catecholamine flow through an adrenorenal rete.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
9.
1981
|
|
| 1981
|
Renal function during reflexly activated catecholamine flow through an adrenorenal rete.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
9.
1981
|
|
| 1981
|
Role of the Renal Nerves in the Pathogenesis of One-Kidney Renal Hypertension in the Rat.
Hypertension.
3:404-409.
1981
|
|
| 1980
|
Diurnal patterns and regulation of cortisol secretion in pregnancy.
Journal of Clinical Endocrinology and Metabolism.
51:466-472.
1980
|
|
| 1980
|
Drug management of hypertension.
Circulation.
61:210-212.
1980
|
|
| 1980
|
Effect of acute hypoxia on the pulmonary conversion of angiotensin I to angiotensin II in dogs.
Circulation Research.
46:221-226.
1980
|
|
| 1980
|
Effect of molecular size and structure on renal tubular processing of peptides
1980
|
|
| 1980
|
Hemodynamic Response to Vascular Expansion Following Immunosympathectomy in Spontaneously Hypertensive Rats.
Hypertension.
2:304-310.
1980
|
|
| 1980
|
Importance of Renal Sympathetic Tone in the Development of DOCA-Salt Hypertension in the Rat.
Hypertension.
2:266-273.
1980
|
|
| 1980
|
Lofexidine in essential hypertension: Double blind comparison with clonidine.
Clinical research.
28.
1980
|
|
| 1980
|
Multiclinic double-blind evaluation of timolol combined with hydrochlorothiazide in essential hypertension
1980
|
|
| 1980
|
NMR observation of altered sodium interaction with human erythrocyte membranes of essential hypertensives.
Biochemical and Biophysical Research Communications.
96:514-521.
1980
|
|
| 1980
|
Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: A study of hemodynamic and humoral factors.
American Journal of Cardiology.
46:559-565.
1980
|
|
| 1980
|
The first year of hypertension.
Hypertension.
2:1-2.
1980
|
|
| 1979
|
Hypertrophy in the denervated heart: A comparison of central sympatholytic treatment with 6-hydroxydopamine and peripheral sympathectomy with nerve growth factor antiserum.
American Journal of Cardiology.
44:970-978.
1979
|
|
| 1979
|
Desoxycorticosterone in normal pregnancy. II. Cortisol-dependent fluctuations in free plasma desoxycorticosterone.
American Journal of Obstetrics and Gynecology.
133:644-648.
1979
|
|
| 1979
|
Hypertension: A new journal.
Hypertension.
1:1-2.
1979
|
|
| 1979
|
Mechanism for renal tubular handling of angiotensin.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
5.
1979
|
|
| 1979
|
Mechanism for renal tubular handling of angiotensin.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
5.
1979
|
|
| 1979
|
Mechanism of angiotensin i converting enzyme inhibition by SQ20,881 (<Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo: Further evidence for extrapulmonary conversion.
Hypertension.
1:13-22.
1979
|
|
| 1979
|
Nomenclature for experimental renovascular hypertension. Report of the Nomenclature Committee of the Council for High Blood Pressure Research of the American Heart Association..
Hypertension.
1:61.
1979
|
|
| 1979
|
Regional myocyte size in normotensive and spontaneously hypertensive rats.
Hypertension.
1:378-383.
1979
|
|
| 1979
|
Renal tubular handling of glucagon and insulin.
Clinical research.
27.
1979
|
|
| 1979
|
The effect of renal denervation on the development of DOCA-salt hypertension in the rat.
Clinical research.
27.
1979
|
|
| 1978
|
Desoxycorticosterone in normal pregnancy. I. Sequential studies of the secretory patterns of desoxycorticosterone, aldosterone, and cortisol.
American Journal of Obstetrics and Gynecology.
132:414-420.
1978
|
|
| 1978
|
Effects of constituent amino acids on tubular handling of microinfused angiotensin II..
American Journal of Physiology.
234.
1978
|
|
| 1978
|
Calcium dependence of angiotensin II induced inhibition of renin release in vitro.
Clinical research.
26.
1978
|
|
| 1978
|
Effects of constituent amino acids on tubular handling of microinfused angiotensin II.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
3.
1978
|
|
| 1978
|
In vivo and in vitro conversion of des-1-Asp angiotensin I to angiotensin III.
Biochemical Pharmacology.
27:2871-2877.
1978
|
|
| 1978
|
Inhibition of renin release from rat kidney slices by the angiotensin.
American Journal of Physiology - Renal Fluid and Electrolyte Physiology.
4.
1978
|
|
| 1978
|
Inhibition of renin release from rat kidney slices by the angiotensins..
American Journal of Physiology.
235.
1978
|
|
| 1978
|
Plasma angiotensin converting enzyme activity in mother and fetus.
Journal of Clinical Endocrinology and Metabolism.
46:434-439.
1978
|
|
| 1978
|
Report of the AFCR public policy committee: current legislative priorities.
Clinical research.
26:330-332.
1978
|
|
| 1978
|
Report of the AFCR public policy committee: current legislative priorities.
Clinical research.
26:121-123.
1978
|
|
| 1978
|
The mechanism of post-arrhythmic renal vasoconstriction in the dog.
Circulation.
58.
1978
|
|
| 1977
|
Sodium and mineralocorticoids in normal and abnormal pregnancy.
1977
|
|
| 1977
|
Changing patterns of corticoid responses to ACTH during normal pregnancy.
Clinical research.
25.
1977
|
|
| 1977
|
Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy.
Circulation Research.
40:428-434.
1977
|
|
| 1977
|
Drug treatment of hypertension.
COMPR.THER..
3:34-36.
1977
|
|
| 1977
|
Handling of angiotensin II and oxytocin by renal tubular segments perfused in vitro.
American Journal of Physiology.
232.
1977
|
|
| 1977
|
Relation of renal hemodynamics to metabolism of angiotensin II by the canine kidney.
Circulation Research.
41:283-287.
1977
|
|
| 1977
|
Treatment of hypertension by computer and physician-A prospective controlled study.
Journal of chronic diseases.
30:81-92.
1977
|
|
| 1976
|
Oral-Contraceptive-Induced Hypertension After Adrenalectomy and Hypophysectomy.
Archives of Internal Medicine.
136:1029-1029.
1976
|
|
| 1976
|
Altered angiotensin I conversion in pulmonary disease.
Clinical science and molecular medicine.
51:537-543.
1976
|
|
| 1976
|
Catecholamines, blood pressure, renin and myocardial function in the spontaneously hypertensive rat.
Clinical science and molecular medicine.
51:455-459.
1976
|
|
| 1976
|
Catecholamines, blood pressure, renin and myocardial function in the spontaneously hypertensive rat..
Clinical science and molecular medicine. Supplement.
3.
1976
|
|
| 1976
|
Inhibition of proximal tubular hydrolysis and reabsorption of angiotensin II by amino acid.
Clinical research.
24.
1976
|
|
| 1976
|
Inhibition of proximal tubular hydrolysis and reabsorption of bradykinin by peptides.
American Journal of Physiology.
231:743-748.
1976
|
|
| 1976
|
Micropuncture evidence of rapid hydrolysis of bradykinin by rat proximal tubule.
American Journal of Physiology.
230:1420-1424.
1976
|
|
| 1976
|
Myocardial function and renin in the spontaneously hypertensive rat after central and peripheral sympathectomy.
Clinical research.
24.
1976
|
|
| 1976
|
Oral-Contraceptive-Induced Hypertension After Adrenalectomy and Hypophysectomy.
Archives of Internal Medicine.
136:1029-1031.
1976
|
|
| 1976
|
Regulation of cortisol (F) secretion in pregnancy.
Clinical research.
24.
1976
|
|
| 1976
|
Structural requirements for the inhibition of renin release in vitro by the angiotensins.
Circulation.
54.
1976
|
|
| 1976
|
Theoretical approaches to estimation of plasma renin activity: a review and some original observations
1976
|
|
| 1976
|
Treatment of essential hypertension with a combination of hydrochlorothiazide, propranolol and methyldopa.
Clinical research.
24.
1976
|
|
| 1975
|
Plasma renin activity in hypertension..
Comprehensive Therapy.
1:57-64.
1975
|
|
| 1975
|
Effect of progesterone on renal sodium handling in man: relation to aldosterone excretion and plasma renin activity.
Clinical science and molecular medicine.
49:139-147.
1975
|
|
| 1975
|
Fate of labeled angiotensin II microinfused into individual nephrons in the rat.
American Journal of Physiology.
228:747-751.
1975
|
|
| 1975
|
Handling of small peptides by rat renal tubules.
Clinical research.
23.
1975
|
|
| 1975
|
Physician acceptance of computer recommended antihypertensive therapy
1975
|
|
| 1975
|
Prevention of Hypertension in the SH Rat: Effects of Differential Central Catecholamine Depletion
1975
|
|
| 1974
|
Studies of plasma bradykininases using radiolabelled substrates.
Australian Journal of Experimental Biology and Medical Science.
52:601-606.
1974
|
|
| 1974
|
Effects of ph and enzyme inhibitors on apparent generation of angiotensin i in human plasma.
Journal of Clinical Endocrinology and Metabolism.
39:965-968.
1974
|
|
| 1974
|
New polypeptide inhibitors of angiotensin conversion.
Clinical research.
22.
1974
|
|
| 1974
|
Structural requirements for substrates and inhibitors of angiotensin I converting enzyme in vivo and in vitro.
Circulation Research.
34:19-26.
1974
|
|
| 1973
|
Mechanism of renal handling of angiotensin II in the dog.
Circulation Research.
33:500-507.
1973
|
|
| 1973
|
Polypeptide inhibitors of angiotensin converting enzyme.
Clinical research.
21:441.
1973
|
|
| 1973
|
Substrate requirements for angiotensin I conversion in vivo and in vitro..
Circulation Research.
32:415-423.
1973
|
|
| 1971
|
Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog..
Circulation Research.
29:682-690.
1971
|
|
| 1971
|
Renin in differential diagnosis of hypertension.
American Heart Journal.
82:568-570.
1971
|
|
| 1970
|
In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood..
Circulation Research.
26:591-599.
1970
|
|
| 1970
|
Role of renin in acute postural homeostasis..
Circulation.
41:89-95.
1970
|
|
| 1966
|
Sex difference in fluid exchange during food deprivation in the rabbit..
Endocrinology.
78:291-296.
1966
|
|
